Technology
Software Service
2016 IPO

Coupa Software

$88.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.32 (-2.57%) Today
-$2.32 (-2.57%) Today

Why Robinhood?

You can buy or sell Coupa Software and other stocks, options, ETFs, and crypto commission-free!

About

Coupa Software Incorporated Common Stock, also called Coupa Software, is cloud platform for business spend. It develops software solutions for sourcing; procurement and expense management that help companies control their spending. Read More The company was founded by Noah Eisner and Dave Stephens in 2006 and is headquartered in San Mateo, CA.

Employees
833
Headquarters
San Mateo, California
Founded
2006
Market Cap
5.36B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.06M
High Today
$90.67
Low Today
$87.80
Open Price
$90.30
Volume
110.57K
52 Week High
$100.00
52 Week Low
$43.89

Collections

Technology
Software Service
2016 IPO
US
North America

News

PR NewswireMar 20

ERCO Worldwide Finds Business Spend Optimization Chemistry With Coupa

SAN MATEO, Calif., March 20, 2019 /PRNewswire/ -- Coupa Software (NASDAQ: COUP), a leader in business spend management (BSM), today announced that ERCO Worldwide, a specialty chemical company based in Toronto, Ontario, Canada, selected Coupa to transform its business by automating its internal spend processes and enabling smoother invoice activities across its supplier base. As ERCO Worldwide continues to build on its 120-year history of delivering a range of products and services to customers around the g...

7
Guru FocusMar 19

Coupa Software Inc (COUP) CEO Robert Bernshteyn Sold $5.9 million of Shares

CEO of Coupa Software Inc (NASDAQ:COUP) Robert Bernshteyn sold 63,225 shares of COUP on 03/18/2019 at an average price of $93.47 a share.

132
Yahoo FinanceMar 14

COUPA SOFTWARE (COUP) Moves to Buy: Rationale Behind the Upgrade

Agenus (AGEN) gets a $7.5-million milestone payment from Gilead following the FDA acceptance of the company's IND filing for AGEN1423. Shares rise.

257

Earnings

-$0.19
-$0.10
-$0.01
$0.08
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
$0.05 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.